Frontiers in Cardiovascular Medicine

Original Research

Published on 05 Feb 2025

Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients

in Heart Valve Disease

Thomas Meredith
Farhan Mohammed
Amy Pomeroy
Sebastiano Barbieri
Erik Meijering
Louisa Jorm
David Roy
Jason Kovacic
Michael Feneley
Christopher Hayward

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1444658

268 views

Review

Published on 30 Jan 2025

Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing

in Heart Valve Disease

Sreyashi Chakraborty
Melinda G. Simon
Alessandro Bellofiore

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1458809

366 views

Systematic Review

Accepted on 24 Jan 2025

Predictors of Significant Tricuspid Regurgitation in Atrial Fibrillation: a meta-analysis

in Heart Valve Disease

Xiuxiu Zhang
Na Zhang
Jia Fu
Dapeng Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1428964

Brief Research Report

Published on 21 Jan 2025

Epigallocatechin gallate (EGCG) modulates senescent endothelial cell-monocyte communication in age-related vascular inflammation

in Heart Valve Disease

Sarvatit Patel
Kai Ellis
Corey A. Scipione
Jason E. Fish
Kathryn L. Howe

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1506360

628 views

Review

Published on 17 Jan 2025

Progress on long non-coding RNAs in calcific aortic valve disease

in Heart Valve Disease

Yan Shen
Jiahui Li
Zehao Zhao
Xiaomin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1522544

482 views

Original Research

Published on 14 Jan 2025

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair

in Heart Valve Disease

Johannes Kirchner
Muhammed Gerçek
Hazem Omran
Kai Peter Friedrichs
Felix Rudolph
Tobias Rossnagel
Misagh Piran
Arseniy Goncharov
Maria Ivannikova
Volker Rudolph

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1463978

413 views

Systematic Review

Published on 10 Jan 2025

The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis

in Heart Valve Disease

Zhili Wei
Xinquan Shao
Zhijing An
Yixuan Chang
Shidong Liu
Ziran Luo
Yang Chen
Bing Song

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1489674

467 views

Review

Published on 08 Jan 2025

Evolving perspectives on aortic stenosis: the increasing importance of evaluating the right ventricle before aortic valve intervention

in Heart Valve Disease

Vitaliy Androshchuk
Omar Chehab
Joshua Wilcox
Benedict McDonaugh
Natalie Montarello
Ronak Rajani
Bernard Prendergast
Tiffany Patterson
Simon Redwood

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1506993

532 views

Review

Published on 19 Dec 2024

Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease

in Heart Valve Disease

Enze Fu
Kai Pan
Zongjin Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1503830

850 views

Original Research

Published on 18 Dec 2024

The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery

in Heart Valve Disease

Natalia Pavone
Federico Cammertoni
Maria Calabrese
Piergiorgio Bruno
Giancarlo Scoppettuolo
Antonella Lombardo
Francesca Giovannenze
Eleonora Taddei
Barbara Fiori
Tiziana D’Inzeo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1504197

501 views

Case Report

Published on 09 Dec 2024

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

in Heart Valve Disease

Benjamin Mothibe Bussmann
Sam Dawkins
James Newton
Thomas Cahill

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1487061

672 views

Review

Published on 19 Nov 2024

The role of pre-existing left-sided valvular heart disease in the prognosis of patients with acute myocardial infarction

in Heart Valve Disease

Tamilla Muzafarova
Zuzana Motovska

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1465723

648 views

Original Research

Published on 21 Oct 2024

Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization

in Heart Valve Disease

Dominik Felbel
Juliana von Winkler
Michael Paukovitsch
Matthias Gröger
Elene Walther
Stefanie Andreß
Leonhard Schneider
Sinisa Markovic
Wolfgang Rottbauer
Mirjam Keßler

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1452446

794 views

Original Research

Published on 03 Oct 2024

Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study

in Heart Valve Disease

Yue Wang
Yusi Shen
Lina Tan
Liangbo Hu
Min He
Xiaocong Zeng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1404284

1,218 views

Original Research

Published on 26 Sep 2024

Higher serum phosphate within the normal range is associated with the development of calcified aortic valve disease

in Heart Valve Disease

Kyung An Kim
Hae-Ok Jung
Mi-Jeong Kim
So-Young Lee
Yuran Ahn
Mi-Hyang Jung
Woo-Baek Chung
Dong-Hyeon Lee
Ho-Joong Youn
Hyuk-Jae Chang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1450757

749 views

Original Research

Published on 24 Sep 2024

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway

in Heart Valve Disease

Qingzhou Yao
Erlinda The
Balachandar Nedumaran
Yufeng Zhai
Lihua Ao
David A. Fullerton
Xianzhong Meng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1410862

676 views

Navigation group

Articles

Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients

Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing

Predictors of Significant Tricuspid Regurgitation in Atrial Fibrillation: a meta-analysis

Epigallocatechin gallate (EGCG) modulates senescent endothelial cell-monocyte communication in age-related vascular inflammation

Progress on long non-coding RNAs in calcific aortic valve disease

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair

The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis

Evolving perspectives on aortic stenosis: the increasing importance of evaluating the right ventricle before aortic valve intervention

Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease

The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

The role of pre-existing left-sided valvular heart disease in the prognosis of patients with acute myocardial infarction

Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization

Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study

Higher serum phosphate within the normal range is associated with the development of calcified aortic valve disease

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway